Efficacy of Biological Therapy in Pediatric Inflammatory Bowel Disease
ConditionEffect of Drug
Trial statusNot yet recruiting
Trial phaseEarly Phase 1
Trial typeInterventional
Biological sexAll
Age1-16
SponsorAin Shams University
About this trial
Compare efficacy of different biologicals in induction of remission including clinical, laboratory and histopathological remission.
Eligibility criteria
Qualifiers
None
Disqualifiers
None
Trial design
Treatments tested in this trial
- Group 1 of patients will receive Adalimumab while Group 1 will receive ustekinumab
Treatment groups
40 Participants
are divided into 1 treatment groupLocations
Sponsors and collaborators
Source ClinicalTrials.gov